Wall Street’s Best Investments Daily Alert: Buy (ZBH)

You are trying to access subscriber-only content.

If you are a subscriber, log in here.

If you are not a subscriber, click here for your subscription. Subscribers will have unlimited access to our magazine articles and more!

Article Excerpt

This medical and surgical products company beat earnings estimates by a nickel last quarter. Current forecasts are 15.5% growth for 2017. Zimmer Biomet Holdings (ZBH) From Cabot Benjamin Graham Value Investor Zimmer Biomet Holdings (ZBH; Max Buy Price 127.87) designs, manufactures and markets a variety of medical and surgical products for orthopedic reconstruction, sports medicine, […]

Comments

You must be logged in to post a comment.